Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Fennec Pharmaceuticals Inc. (T.FRX) had Debt to Equity Ratio of -2.42 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-4.36M |
|
-- |
|
-- |
|
-- |
|
-3.78M |
|
-- |
|
-4.36M |
|
-4.36M |
|
-4.36M |
|
-4.36M |
|
-4.36M |
|
-4.36M |
|
-3.78M |
|
-3.76M |
|
27.66M |
|
27.66M |
|
-0.15 |
|
-0.15 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
62.08M |
|
-- |
|
-- |
|
-- |
|
72.40M |
|
-10.32M |
|
-10.32M |
|
-10.32M |
|
27.73M |
|
| Cash Flow Statement Financials | |
-11.07M |
|
-- |
|
0.10M |
|
36.84M |
|
25.87M |
|
-10.97M |
|
3.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.85 |
|
-- |
|
-- |
|
1.70 |
|
|
Debt to Equity Ratio |
-2.42 |
89.98% |
|
-28.30% |
|
-28.30% |
|
-- |
|
-32.66% |
|
-32.66% |
|
-11.07M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
0.44 |
|
0.55 |
|
163.20 |
|
42.23% |
|
42.23% |
|
-7.02% |
|
-29.65% |
|
-0.37 |
|
-0.40 |
|
-0.40 |
|